Bernard Le Foll

48PUBLICATIONS
107CO-AUTHORS
Toxicology (incl. clinical toxicology)Health psychologyInstrumental methods (excl. immunological and bioassay methods)Molecular medicineRace/ethnicity and crime
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Aug 07, 2026
Uncertain Benefit and Potential Harms of Serotonergic Antidepressants in Persons With Substance Use Disorder.

|May 20, 2026
Cannabis Legalization Outcomes in Canada: Trading Off Increased Health Problem for Reduced Crime Burdens Is Not Good Enough.

|May 09, 2026
PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence.

|Mar 17, 2026
Correction: Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development.

Bernard Le Foll, Mickael Naassila, Jérôme Jeanblanc

|Feb 27, 2026
Racial discrimination in healthcare and public settings as a predictor of suicidal ideation onset among U.S. Adults with baseline depressive symptoms.

Soyeon Kim, Florence Tang, Linas Wilkialis

|Jan 29, 2026
Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development.

Bernard Le Foll, Mickael Naassila, Jérôme Jeanblanc

Pageof 8

Frequent Collaborators

7 joint publications

Didier Jutras-Aswad

6 joint publications

Stefan Kloiber

6 joint publications

Justin Matheson

6 joint publications

Isabelle Boileau